Your browser doesn't support javascript.
loading
Effectiveness of Modified Vaccinia Ankara-Bavaria Nordic Vaccination in a Population at High Risk of Mpox: A Spanish Cohort Study.
Fontán-Vela, Mario; Hernando, Victoria; Olmedo, Carmen; Coma, Ermengol; Martínez, Montse; Moreno-Perez, David; Lorusso, Nicola; Vázquez Torres, María; Barbas Del Buey, José Francisco; Roig-Sena, Javier; Pastor, Eliseo; Galmés Truyols, Antònia; Artigues Serra, Francisca; Sancho Martínez, Rosa María; Latasa Zamalloa, Pello; Pérez Martínez, Olaia; Vázquez Estepa, Ana; García Rojas, Amós José; Barreno Estévez, Ana Isabel; Sánchez-Migallón Naranjo, Alonso; Pérez Martín, Jaime Jesús; Peces Jiménez, Pilar; Morales Romero, Raquel; Castilla, Jesús; García Cenoz, Manuel; Huerta Huerta, Marta; Boone, An Lieve Dirk; Macías Ortiz, María José; Álvarez Río, Virginia; Rodríguez Recio, María Jesús; Merino Díaz, María; Berradre Sáenz, Belén; Villegas-Moreno, María Teresa; Limia, Aurora; Diaz, Asuncion; Monge, Susana.
Affiliation
  • Fontán-Vela M; National Centre of Epidemiology, Institute of Health Carlos III, Community of Madrid, Spain.
  • Hernando V; Public Health and Epidemiology Research Group, School of Medicine and Health Sciences, Universidad de Alcalá, Alcalá de Henares, Community of Madrid, Spain.
  • Olmedo C; National Centre of Epidemiology, Institute of Health Carlos III, Community of Madrid, Spain.
  • Coma E; CIBER on Infectious Diseases, Madrid, Spain.
  • Martínez M; Vaccination Programme, General Directorate of Public Health, Ministry of Health, Madrid, Spain.
  • Moreno-Perez D; Primary Healthcare Information Systems, Health Institute of Catalonia, Catalonia, Spain.
  • Lorusso N; Preventive Medicine Service, General Sub-directorate for Health Promotion, Health Department, Secretariat of Public Health,Catalonia, Spain.
  • Vázquez Torres M; Health and Consumption Department, General Directorate of Public Health and Pharmaceutical Management, Andalusia, Spain.
  • Barbas Del Buey JF; Health and Consumption Department, General Directorate of Public Health and Pharmaceutical Management, Andalusia, Spain.
  • Roig-Sena J; Healthcare Department, General Sub-directorate of Health Prevention and Promotion, General Directorate of Public Health, Community of Madrid, Spain.
  • Pastor E; General Sub-directorate of Public Health Surveillance, General Directorate of Public Health, Madrid, Community of Madrid, Spain.
  • Galmés Truyols A; Department of Universal Healthcare and Public Health, Epidemiological Surveillance Service, Valencian Community, Spain.
  • Artigues Serra F; Universal Healthcare and Public Health Department, Health Promotion and Prevention Programs Service, Valencian Community, Spain.
  • Sancho Martínez RM; Disease Prevention Service, Health and Consumption Department, General Directorate of Public Health and Participation, Balearic Islands, Spain.
  • Latasa Zamalloa P; Disease Prevention Service, Health and Consumption Department, General Directorate of Public Health and Participation, Balearic Islands, Spain.
  • Pérez Martínez O; Epidemiology Unit, General Sub-directorate of Public Health and Addictions of Gipuzkoa, Basque Country, Spain.
  • Vázquez Estepa A; Epidemiology and Vaccination Service, General Directorate of Public Health, Basque Country, Spain.
  • García Rojas AJ; Epidemiology Service, Health Department, General Directorate of Public Health, Galicia, Spain.
  • Barreno Estévez AI; Epidemiology Service, Health Department, General Directorate of Public Health, Galicia, Spain.
  • Sánchez-Migallón Naranjo A; Prevention and Epidemiology Service, General Directorate of Public Health, Canarian Health Service, Canary Islands, Spain.
  • Pérez Martín JJ; Prevention and Epidemiology Service, General Directorate of Public Health, Canarian Health Service, Canary Islands, Spain.
  • Peces Jiménez P; Epidemiology Service, Health Department, General Directorate of Public Health and Addictions, Murcia Region, Spain.
  • Morales Romero R; Vaccination Progamme, Prevention and Health Protection Service, Health Department, General Directorate of Public Health and Addictions, Murcia Region, Spain.
  • Castilla J; Epidemiology Service, Healthcare Department, General Directorate of Public Health, Castilla-La Mancha, Spain.
  • García Cenoz M; Epidemiology Service, Healthcare Department, General Directorate of Public Health, Castilla-La Mancha, Spain.
  • Huerta Huerta M; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain.
  • Boone ALD; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain.
  • Macías Ortiz MJ; Vaccination Programme, Health Department, Epidemiological Surveillance Service, Principado de Asturias, Spain.
  • Álvarez Río V; Vaccination Programme, Health Department, Epidemiological Surveillance Service, Principado de Asturias, Spain.
  • Rodríguez Recio MJ; Vaccination Program, General Directorate of PublicHealth, Healthcare Service of Extremadura, Spain.
  • Merino Díaz M; Epidemiology Service, Healthcare Department, General Directorate of Public Health, Castilla y León, Spain.
  • Berradre Sáenz B; Epidemiology Service, Healthcare Department, General Directorate of Public Health, Castilla y León, Spain.
  • Villegas-Moreno MT; Epidemiology and Healthcare Prevention Service, Health Department, General Directorate of Public Health, Consumption and Nursing, La Rioja, Spain.
  • Limia A; Epidemiology and Healthcare Prevention Service, Health Department, General Directorate of Public Health, Consumption and Nursing, La Rioja, Spain.
  • Diaz A; National Centre of Epidemiology, Institute of Health Carlos III, Community of Madrid, Spain.
  • Monge S; Vaccination Programme, General Directorate of Public Health, Ministry of Health, Madrid, Spain.
Clin Infect Dis ; 78(2): 476-483, 2024 02 17.
Article in En | MEDLINE | ID: mdl-37864849

Full text: 1 Database: MEDLINE Main subject: Vaccinia / Vaccines / HIV Infections / Mpox (monkeypox) Limits: Adolescent / Adult / Humans Language: En Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Main subject: Vaccinia / Vaccines / HIV Infections / Mpox (monkeypox) Limits: Adolescent / Adult / Humans Language: En Year: 2024 Type: Article